GENE ONLINE|News &
Overview of the Gene Therapy Revolution: Hopeful Beginnings, Tribulations, and Resurgence
Gene therapy is a hot commodity in the biopharma business, attracting profitable investments and expensive M&A transactions in recent years.
Moreover, the frequent reports of research breakthroughs and clinical trial gains are an indication of the steady progress of the field. In 2019, the gene therapy market was valued at $3.61 billion. It is predicted to grow further at a CAGR of 33.6% and reach $35.67 billion by 2027, according to a forecast released by Fortune Business Insights™.
Moreover, the frequent reports of research breakthroughs and clinical trial gains are an indication of the steady progress of the field. In 2019, the gene therapy market was valued at $3.61 billion. It is predicted to grow further at a CAGR of 33.6% and reach $35.67 billion by 2027, according to a forecast released by Fortune Business Insights™.
GO Prime with only $1.49 now
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
